(Q33560077)

English

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Goa KL

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Bryson HM

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

56-77

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamic assessment of quality of life after autologous bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of molgramostim in marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosage standardization for filgrastim

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Financial risk, hospital cost, and complications and comorbidities in medical non-complications and comorbidity-stratified diagnosis-related groups

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current guidelines on the use of antibacterial drugs in patients with malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost implications of haematopoietic growth factors in the BMT setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitoxantrone/high-dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GM-CSF as an adjunct to autologous bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I/II study of dose and administration of non-glycosylated bacterially synthesized G-M CSF in chemotherapy-induced neutropenia in patients with non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approaching the controversies in antibacterial management of cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The distinction between cost and charges

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomics of intravenous drug administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous bone marrow transplants: different indications in Europe and North America. Advisory Committee of the International Autologous Bone Marrow Transplant Registry (ABMTR)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ganciclovir with recombinant methionyl human granulocyte colony-stimulating factor for treatment of cytomegalovirus disease in AIDS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony-stimulating factor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated hemopoietic recovery after chemotherapy and autologous bone marrow transplantation in hematological malignancies using recombinant GM-CSF: preliminary results obtained in 14 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strategic management of biotechnology agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs and cost-minimisation analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The national economic burden of cancer: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principles of pharmacoeconomic analysis of drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Considerations for the prevention of infectious complications in patients with cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoprophylaxis of gram-negative infections in neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating the treatment costs of breast and lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomic issues in the use of granulocyte-macrophage colony-stimulating factor for bone marrow transplantation or chemotherapy-induced neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony stimulating factor (GM-CSF) as an adjunct to autologous bone marrow transplantation (ABMT) in hematology. Results of the interim analysis of the Schering-Plough/Sandoz International trial and considerations on increased

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective physician review of orders for colony-stimulating factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of recombinant human granulocyte-macrophage colony stimulating factor on progenitor cells in patients with advanced malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric treatment of localized infections in the febrile neutropenic patient with monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Valuing Clinical Strategies Early in Their Development

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life during and after treatment of Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empirical antibiotics for febrile neutropenic cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomics of antimicrobial prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10146867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199405010-00008

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33560077&oldid=2195489756"